With shares of�Corning Inc.�(NYSE:GLW) trading at around $16.35, is GLW an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
C = Catalyst for the Stock�� Movement
Corning has been making new 52-week highs as of late, but is this trend sustainable? In this stock market environment, anything is possible. However, that doesn�� mean all moves are justifiable.
Corning Incorporated produces and sells specialty glasses, ceramics, and related materials worldwide. It operates through five segments: Display Technologies, Telecommunications, Environmental Technologies, Specialty Materials, and Life Sciences.
Corning has a diverse revenue base. There is currently high demand for tablets and smartphones, Gorilla Glass has received many positive reviews, Q1 estimates were recently beat, there have been cost and efficiency improvements, revenue has increased for three consecutive years, and the stock is at a good valuation, trading at 14 times earnings, while the industry trades at 19 times earnings. However, when you look at the breakdown for the last quarter, there is good reason for caution. The only segment that showed improvement was Life Sciences. Corning is confident in future growth, but that doesn�� mean confidence will lead to actual results.
10 Best Building Product Stocks To Watch Right Now: WisdomTree International Dividend Ex Financial Fund (DOO)
WisdomTree International Dividend Top 100 Fund (The Fund) is a non-diversified fund. It seeks investment results that closely correspond to the price and yield performance, before fees and expenses, of the WisdomTree International Dividend Top 100 Index (The Index). The fund is managed by WisdomTree Asset Management, Inc.
The Index measures the performance of the 100 highest dividend-yielding companies in the WisdomTree International LargeCap Dividend Index. The Index is created by selecting the top 100 companies ranked by highest dividend yield from the WisdomTree International LargeCap Dividend Index.
Advisors' Opinion:- [By Eric Lam]
��ompanies that come to market are coming from sectors that work,��said Brian Huen, managing partner at Red Sky Capital Management Ltd. in Toronto. He helps manage C$220 million with the firm, and participated in the offerings for Choice Properties, Information Services Corp., and Ski-Doo maker BRP Inc. (DOO) ��eople certainly aren�� bringing any gold IPOs to market. So investors are focusing on buying deals in the right markets, as opposed to the wider market which has exposure to resources.��
Top Life Sciences Stocks To Invest In Right Now: Titan Company Ltd (TITAN)
Titan Company Limited, formerly Titan Industries Limited, is engaged in manufacturing of watches/accessories, jewelry, precision engineering and eyewear. The Company has four divisions: watches/accessories, jewelry, precision engineering and eyewear. As of March 31, 2012, the Company had 332 World of Titan stores. As of March 31, 2012, the Company had over three business units in Bangalore, India, a manufacturing unit at Hosur and three assembly plants located in the north of India. The brands under the watches/accessories division include: Titan, Sonata, Fastrack, Xylys and others. Tanishq is Titan�� line of jewelry with a range of jewelry, studded with diamonds or colored gems in 18-karat gold, 22-karat gold and platinum jewelry. Under eyewear division, there is a brand named Titan Eye plus. The precision engineering division includes machine building and automation solutions and tooling solutions. In March 2013, Titan Properties Ltd. was amalgamated with the Company. Advisors' Opinion:- [By James Miller Phd]
Peers like Microsoft Corp. (MSFT) and Oracle Corp. (ORCL) present strong competition in the could-based CRM market, and have been enhancing their companies through various acquisitions such as recently acquired Nimbula, Eloqua Inc., RightNow Technologies and Taleo Corp from Oracle, or MarketingPilot and Netbreeze from Microsoft. Competition is moreover expected to increase with the introduction of Microsoft Dynamics CRM software (Titan). Nevertheless, Salesforce has also been strengthening its product portfolio and expanding within the cloud based CRM services.
Top Life Sciences Stocks To Invest In Right Now: Infoblox Inc (BLOX)
Infoblox Inc. (Infoblox), incorporated in May 2003, is an automated network controller. The Company�� network functions include Internet protocol (IP) address management, device configuration, compliance, network discovery, policy implementation, security and monitoring. The Company�� appliance-based solution combines real-time IP address management with the automation of key network control and network change and configuration management processes in purpose-built physical and virtual appliances. It is based on its software that is scalable and automates vital network functions, such as IP address management, device configuration, compliance, network discovery, policy implementation, security and monitoring. It offers two families of products: Trinzic Enterprise and Trinzic NetMRI. The Trinzic Enterprise product family enables real-time IP address management and automates key network control processes. The Trinzic NetMRI product family automates network change and configuration management processes.
Trinzic Enterprise Family
The Company derives its product revenue from its Trinzic Enterprise family of products. The components of its Trinzic Enterprise family, are Trinzic Enterprise, Trinzic IPAM for Microsoft, Trinzic Reporting and Trinzic IPAM Insight. Its Trinzic Enterprise product is an appliance that is designed to for continuous operation of network control. Trinzic Enterprise offers file delivery services via the File Transfer Protocol (FTP), Trivial File Transfer Protocol (TFTP), and Hypertext Transfer Protocol (HTTP), time synchronization services via the Network Time Protocol (NTP) and Logging services via Syslog.
Trinzic IPAM for Microsoft provides a single, Web-based management interface for the centralized management of DNS, DHCP and multiple IP address pools running on Microsoft servers without any installation of software on Microsoft servers. It also provides Microsoft server management capabilities, such as centralized IP address management! , DNS changes and individualized, role-based access control. Trinzic Reporting provides long-term reporting, trending, analysis and tracking capabilities to report network utilization, isolate performance problems, implement DHCP and DNS capacity planning and identify security threats. Trinzic Reporting automates tasks associated with collecting, tabulating and correlating data and displays the information through its Web-based management interface. Trinzic IPAM Insight allows automated discovery of network device configuration information used in automation and compliance reporting.
Trinzic NetMRI Family
The Company�� Trinzic NetMRI products components of include Trinzic Network Automation, Trinzic Network Compliance, Trinzic Switch Port Manager and Trinzic PCI Insight. Its Trinzic NetMRI product automates network change and configuration management processes. Trinzic NetMRI enables information technology organizations to automate network changes, gain visibility into the impact of changes occurring on the network, manage network configurations, archive network configurations and meet a range of compliance requirements for both physical and virtual machines. Trinzic NetMRI discovers and monitors network infrastructure devices to determine critical network information. It uses this information to analyze network stability, to identify unauthorized devices and to take inventory of network devices for inventory management and/or troubleshooting. Trinzic Network Automation automates network configuration functions.
Trinzic Network Compliance automates the network compliance process, meeting corporate security requirements and providing the necessary information and control for internal and external compliance mandates. Trinzic Network Compliance also automatically alerts IT personnel in the event of a failure to meet compliance guidelines and permits the establishment and deployment of specific end customer requirements with click and drag simplicity, supporting ! complianc! e mandates such as those under the Payment Card Industry Data Security Standard (PCI DSS), the Health Insurance Portability and Accountability Act of 1996 (HIPAA), the Sarbanes-Oxley Act, Federal Energy Regulatory Commission (FERC) and North American Electric Reliability Corporation (NERC).
Trinzic Switch Port Manager enables its end customers to identify the number of switch ports, manage them precisely and locate the next available switch port. It helps provide views and management of switches with both current and historical IP addresses, MAC addresses, VLAN mappings and network device topology information. It also shows where devices have been connected, when they connected and where they are currently connected so that the network administrator can easily track authorized devices and find rogue devices that can pose security risks and create network instability. Trinzic PCI Insight is an integrated offering that bundles Trinzic Network Compliance, Trinzic IPAM Insight from its Trinzic Enterprise family of products and consulting services and enables its end customers to optimize their PCI DSS compliance.
The Company competes with BMC Software, Inc., EMC Corporation, Hewlett-Packard Company and International Business Machines Corporation, Alcatel-Lucent, BT Group plc and BlueCat Networks, Inc.
Advisors' Opinion:- [By Rich Bieglmeier]
[Related -Infoblox Inc (BLOX): Getting off the Mat?]
Infoblox is an automated network controller. The Company's network functions include Internet protocol (IP) address management, device configuration, compliance, network discovery, policy implementation, security and monitoring.
- [By Evan Niu, CFA]
What: Shares of Infoblox (NYSE: BLOX ) have popped today by as much as 18% after the company reported earnings.
So what: Revenue in the fiscal third quarter came in at a record $58 million, topping the Street's $56 million forecast. Non-GAAP earnings per share totaled $0.11, also ahead of the $0.06-per-share adjusted profit that investors were expecting. CEO Robert Thomas said the company's value proposition -- helping networks become more automated and secure -- is driving its outperformance.
- [By Lauren Pollock]
Among the companies with shares expected to actively trade in Wednesday’s session are Hewlett-Packard Co.(HPQ), Infoblox Inc.(BLOX), and Tilly's Inc.(TLYS)
Top Life Sciences Stocks To Invest In Right Now: PHI Inc.(PHII)
PHI, Inc., together with its subsidiaries, provides helicopter transportation services to the integrated energy, and independent exploration and production companies primarily in the Gulf of Mexico and internationally. The company operates in three segments: Oil and Gas, Air Medical, and Technical Services. The Oil and Gas segment provides helicopter services to oil and gas exploration and production companies, and other offshore oil service companies primarily for routine transportation of personnel and equipment; transportation of personnel during medical and safety emergencies; and evacuation of personnel during the threat of hurricanes and other adverse weather conditions. The Air Medical segment provides air medical transportation services for hospitals and emergency service agencies in 17 states. The Technical Services segment offers helicopter repair and overhaul services for existing flight operations customers. It also operates 5 aircrafts for the National Science Foundation in Antarctica. As of December 31, 2011, it owned or operated 259 aircrafts, including 167 aircrafts by Oil and Gas segment, 86 aircrafts by Air Medical segment, and 6 for other operations. The company was formerly known as Petroleum Helicopters, Inc. and changed its name to PHI, Inc. in December 2005. PHI, Inc. was founded in 1949 and is based in Lafayette, Louisiana.
Advisors' Opinion:- [By Monica Gerson]
PHI (NASDAQ: PHII) shares jumped 97.46% to reach a new 52-week high of $80.96. PHI shares have jumped 26.08% over the past 52 weeks, while the S&P 500 index has gained 15.37% in the same period.
Top Life Sciences Stocks To Invest In Right Now: The Hackett Group Inc.(HCKT)
The Hackett Group, Inc. operates as a strategic advisory and technology consulting firm primarily in the United States and western Europe. The company offers executive advisory programs, benchmarking, business transformation, and technology consulting services, as well as shared services, offshoring, and outsourcing advice. Its executive advisory programs consists of advisor inquiry, an inquiry service used by clients for access to fact-based advice on proven approaches and methods to increase the effectiveness of selling, general, and administrative processes (SG&A); best practice research, a research that provides insights into the proven approaches in use at organizations; peer interaction program comprising member-led Webcasts, annual Best Practice Conferences, annual Member Forums, membership performance surveys, and client-submitted content; and best practice intelligence center, an online, searchable repository of practices, performance metrics, conference presentat ions, and associated research. The company?s bench marking services conduct studies in the areas of SG&A, finance, human resources, information technology, procurement, enterprise performance management, shared service centers, and working capital management. These services are used by clients to establish priorities, generate organizational consensus, align compensation to establish performance goals, and develop the required business case for business and technology investments. Its business transformation programs help clients to develop coordinated strategy for achieving performance improvements across the enterprise; and Hackett Technology Solutions help clients choose and deploy the software applications that meet their needs and objectives. The company was formerly known as Answerthink, Inc. and changed its name to The Hackett Group, Inc. in January 2008. The Hackett Group, Inc. was founded in 1991 and is headquartered in Miami, Florida.
Advisors' Opinion:- [By ValueArtifex]
One such situation currently in the process of unfolding this month is a Dutch Tender by The Hackett Group (HCKT). I will briefly discuss the underlying business, what exactly a Dutch Auction (or in this case, a Tender) is, what options investors have when approaching this situation and how it could play out.
Top Life Sciences Stocks To Invest In Right Now: Hersha Hospitality Trust (HT)
Hersha Hospitality Trust, a real estate investment trust, engages in the ownership and operation of mid scale limited service hotels in the Eastern United States. As of June 30, 2005, it owned interests in 35 hotels, including 4 hotels owned through joint ventures in Pennsylvania, New York, New Jersey, Maryland, Georgia, Connecticut, and Massachusetts. The company has elected to be taxed as a REIT under the Internal Revenue Code. As a REIT, Hersha would not be subject to income tax to the extent it distributes at least 90% of its taxable income to its stockholders. The company was founded in 1998 and is headquartered in New Cumberland, Pennsylvania.
Advisors' Opinion:- [By George Putnam]
Steve Halpern: Now, you've also looked at a company called Hersha Hospitality (HT). How are they involved in the industry?
George Putnam: Well, Hersha, again, has been refocusing its business. It was a little unfocused before. It had both a suburban and urban market, and it's recently agreed to sell the last of its suburban properties.
- [By Markus Aarnio]
American Hotel Income Properties' competitors include Hospitality Properties Trust (HPT), RLJ Lodging Trust (RLJ), and Hersha Hospitality Trust (HT).
Top Life Sciences Stocks To Invest In Right Now: Vanda Pharmaceuticals Inc.(VNDA)
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system disorders. Its lead product includes Fanapt for the acute treatment of schizophrenia in adults. The company is also developing Tasimelteon, an orphan medicinal product for the treatment of sleep and mood disorders, including non-24 hour sleep/wake disorder in blind individuals without light perception. It also intends to initiate a Phase IIb/III clinical trial of tasimelteon in patients with major depressive disorder; and conduct additional clinical trials to support the use of tasimelteon as a circadian regulator. The company was incorporated in 2002 and is headquartered in Rockville, Maryland.
Advisors' Opinion:- [By Paul Ausick]
Stocks on the Move: Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is up 95.8% at $13.29 on FDA recommendation for approval of its sleep drug for the blind. Sarepta Therapeutics Inc. (NASDAQ: SRPT) is down 64.3% at $13.05 following an FDA rejection of the company�� bid to fast-track muscular dystrophy drug. U.S. Airways Group Inc. (NYSE: LCC) is up 1.1% at $23.53 after reaching an agreement with the Department of Justice that will let the company go ahead with its American Airlines merger.
- [By C.R. Jackson]
On April 18, 2013, Vanda Pharmaceuticals (VNDA) stock reached a 52-week high. Why?
Until recently, many investors had given up on the Washington, DC-based pharmaceutical company. The reason was Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia, that not only had a rocky regulatory history, but was a big dud at the sales counter.
- [By Ben Levisohn]
It was the night before the ECB–and two before US payrolls–and all through the market nothing was stirring, not even…Alright. Some things were stirring, like the shares of Protective Life (PL), Travelers Companies (TRV), Under Armour (UA), Broadcom (BRCM) and Vanda Pharmaceuticals (VNDA).
- [By Nathalie Tadena]
Among the companies with shares expected to actively trade in Friday’s session are Vanda Pharmaceuticals Inc.(VNDA), Kimberly-Clark(KMB) and Cell Therapeutics(CTIC).
No comments:
Post a Comment